Founded in 2008, Milpitas, CA based ASC is a developer of gene modification technologies designed to leverage stem cell and genome engineering expertise to advance in next-generation biomedical research and industrial biotechnology. ASC’s gene modification technologies are used to offer precision-engineered cell lines and animal models along with customizable deliverables for every project, enabling researchers to offer enhanced molecular diagnostics and personalized patient care